Table 1 Baseline characteristics
Total (n = 197) | Non-diabetic (n = 113) | Diabetic (n = 84) | p-value | |
|---|---|---|---|---|
Age(years) | 59.2 ± 11.1 | 57.9 ± 11.0 | 60.9 ± 11.0 | 0.069 |
Gender(male), n(%) | 142(72.1) | 82(72.6) | 59(70.2) | 0.646 |
Hypertension, n(%) | 128(65) | 67(59.3) | 61(72.6) | 0.063 |
Hyperlipidemia, n(%) | 45(22.8) | 21(18.6) | 24(28.6) | 0.106 |
Current smokers, n(%) | 101(51.3) | 59(52.2) | 41(48.8) | 0.592 |
BMI(kg/m2) | 25.2 ± 5.3 | 25.4 ± 4.9 | 25.1 ± 5.7 | 0.684 |
SYNTAX | 16.4 ± 12.2 | 16.0 ± 11.9 | 17.0 ± 12.6 | 0.546 |
SYNTAX > 22, n(%) | 60(30.5) | 35(31.3) | 25(29.8) | 0.823 |
Lab data | ||||
HbA1c(%) | 6.4 ± 1.2 | 5.7 ± 0.4 | 7.3 ± 1.3 | <0.3* |
Triglyceride(mmol/l) | 1.8 ± 1.6 | 1.6 ± 0.8 | 2.0 ± 1.8 | 0.073 |
LDL cholesterol(mmol/l) | 2.6 ± 1.0 | 2.6 ± 1.0 | 2.5 ± 1.0 | 0.775 |
HDL cholesterol(mmol/l) | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.045* |
Creatinine(μmol/l) | 79.0 ± 17.6 | 77.8 ± 17.5 | 80.6 ± 17.7 | 0.260* |
Medications | ||||
ACEI, n(%) | 21(10.7) | 11(9.7) | 10(11.9) | 0.641 |
ARB, n(%) | 17(8.6) | 6(5.3) | 11(13.1) | 0.057 |
β-blockers, n(%) | 35(17.8) | 21(18.6) | 14(16.7) | 0.706 |
Calcium channel blockers, n(%) | 44(22.3) | 14(12.4) | 30(35.7) | <0.3* |
Statins, n(%) | 32(16.2) | 10(8.8) | 22(26.2) | 0.9* |